Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.

BJU international - 1 Nov 2011

St Sauver Jennifer L, Lieber Michael M, Slager Susan L, Jacobson Debra J, McGree Michaela E, Jacobsen Steven J

Abstract excerpt

OBJECTIVE: To determine if polymorphisms in the cyclooxygenase 2 (COX-2) enzyme gene (prostaglandin synthase 2; PTGS2) were associated with development of benign prostate enlargement (BPE), and whether associations were modified by use of nonsteroidal anti-inflammatory drugs (NSAIDs). MATERIALS A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclooxygenase 2

Share to Genetic Predisposition to Disease

Share to Organ Size

Share to Polymorphism, Single Nucleotide

Share to Prostatic Hyperplasia

Source

Open in PubMed Open full text

Identifiers

PMID: 21481131
DOI: 10.1111/j.1464-410X.2011.10161.x
PMCID: PMC3315350

Genes

PTGS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21481131-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.PMID 21481131Read ↗

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk.Semantic proximity Read ↗

Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.Semantic proximity Read ↗

Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies.Semantic proximity Read ↗

Association between two single nucleotide polymorphisms of the Prostaglandin-Endoperoxide Synthase 1 and 2 genes and cell proliferative prostatic diseases in Lebanon.Semantic proximity Read ↗

Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.Semantic proximity Read ↗

PTGS2-899G>C and prostate cancer risk: a population-based nested case-control study (ProtecT) and a systematic review with meta-analysis.Semantic proximity Read ↗

Meta-analysis of epidemiological studies demonstrates significant association of PTGS2 polymorphism rs689470 and no significant association of rs20417 with prostate cancer.Semantic proximity Read ↗

Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway.Semantic proximity Read ↗

Genetic variation in the COX-2 gene and the association with prostate cancer risk.Semantic proximity Read ↗

Association between the 8473T>C polymorphism of PTGS2 and prostate cancer risk: a metaanalysis including 24,716 subjects.Semantic proximity Read ↗

Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians.Semantic proximity Read ↗

Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.